| MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma (NCT04555551) | Memorial Sloan Kettering Cancer Center | 2020-09-08 |
| Evaluate the Safety and Clinical Activity of HH2853 (NCT04390737) | Haihe Biopharma Co., Ltd. | 2020-09-08 |
| Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers (NCT04485481) | Q32 Bio Inc. | 2020-09-08 |
| Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer (NCT04631835) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2020-09-08 |
| The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma (NCT04875728) | M.D. Anderson Cancer Center | 2020-09-08 |
| First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors (NCT04564417) | Pierre Fabre Medicament | 2020-09-08 |
| Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL (NCT04240704) | Novartis Pharmaceuticals | 2020-09-07 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema (NCT04292912) | GlaxoSmithKline | 2020-09-07 |
| Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above (NCT05815264) | Ab&B Bio-tech Co., Ltd.JS | 2020-09-07 |
| Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects (NCT05088343) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-07 |
| Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus (NCT04519073) | Virometix | 2020-09-07 |
| FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT04551885) | Fate Therapeutics | 2020-09-07 |
| Pharmacokinetics and Safety of AmBisome and DKF-5122 (NCT05749380) | Dongkook Pharmaceutical Co., Ltd. | 2020-09-07 |
| A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers (NCT04451811) | Oppilan Pharma Ltd | 2020-09-07 |
| A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors (NCT04446260) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-07 |
| Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus (NCT04510090) | Escient Pharmaceuticals, Inc | 2020-09-07 |
| AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism (NCT05239221) | Alexion Pharmaceuticals, Inc. | 2020-09-07 |
| Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers (NCT04328766) | Daewoong Pharmaceutical Co. LTD. | 2020-09-06 |
| Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects (NCT07054255) | Haisco Pharmaceutical Group Co., Ltd. | 2020-09-06 |
| This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) (NCT04593641) | Celltrion | 2020-09-04 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors (NCT04242199) | Incyte Corporation | 2020-09-04 |
| Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions (NCT04938856) | University of Karachi | 2020-09-04 |
| A Study of KC1036 in Patients with Advanced Solid Tumors (NCT04387916) | Beijing Konruns Pharmaceutical Co., Ltd. | 2020-09-04 |
| Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase (NCT04195347) | St. Jude Children's Research Hospital | 2020-09-04 |
| Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years (NCT05976100) | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 2020-09-04 |
| A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT04240002) | Astellas Pharma Global Development, Inc. | 2020-09-04 |
| Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04550442) | M.D. Anderson Cancer Center | 2020-09-04 |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC) (NCT04385290) | Technische Universität Dresden | 2020-09-04 |
| Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia (NCT04578210) | Instituto de Investigación Hospital Universitario La Paz | 2020-09-04 |
| A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer (NCT04474470) | TyrNovo Ltd. | 2020-09-03 |
| Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid Tumors (NCT04478461) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2020-09-03 |
| Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome (NCT04355689) | Nacuity Pharmaceuticals, Inc. | 2020-09-03 |
| A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors (NCT05593094) | Hoffmann-La Roche | 2020-09-03 |
| A Safety Study of LY3493269 in Healthy Participants (NCT04498390) | Eli Lilly and Company | 2020-09-03 |
| Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma (NCT04537442) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2020-09-03 |
| A Trial of Hetrombopag in Healthy Subjects (NCT05088174) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-03 |
| "Prescribing" Exercise to Cancer Patients At High-Risk for Falls (NCT04236154) | Mayo Clinic | 2020-09-03 |
| Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors (NCT04864379) | Sir Run Run Shaw Hospital | 2020-09-03 |
| A Pharmacokinetic Study of PLENVU® in Healthy Subjects (NCT03437265) | Norgine | 2020-09-03 |
| Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older (NCT04537208) | Sanofi Pasteur, a Sanofi Company | 2020-09-03 |
| A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy Participants (NCT06180967) | Eli Lilly and Company | 2020-09-03 |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma (NCT04595994) | Grupo Espanol de Investigacion en Sarcomas | 2020-09-02 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (NCT04365101) | Celularity Incorporated | 2020-09-02 |
| Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab (NCT04164069) | Anne Noonan | 2020-09-02 |
| High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) (NCT04383002) | University Health Network, Toronto | 2020-09-02 |
| REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors (NCT04526106) | Elevar Therapeutics | 2020-09-02 |
| A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers (NCT04505137) | Gmax Biopharm Australia Pty Ltd. | 2020-09-02 |
| A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic Function (NCT04482270) | Astellas Pharma Global Development, Inc. | 2020-09-02 |
| ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers (NCT04236219) | Allena Pharmaceuticals | 2020-09-02 |
| Fruquintinib CYP3A Inhibitor and Inducer Study (NCT04557397) | Hutchison Medipharma Limited | 2020-09-02 |
| A Study of JNJ-64251330 in Healthy Participants (NCT04552197) | Janssen Research & Development, LLC | 2020-09-02 |
| A Study of LY3819253 (LY-CoV555) in Healthy Participants (NCT04537910) | Eli Lilly and Company | 2020-09-02 |
| Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis (NCT04348890) | ReveraGen BioPharma, Inc. | 2020-09-01 |
| Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (NCT03513458) | University of North Carolina, Chapel Hill | 2020-09-01 |
| Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer (NCT04526470) | Seoul National University Bundang Hospital | 2020-09-01 |
| Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer (NCT04270149) | Herbert Lyerly | 2020-09-01 |
| A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers (NCT04546256) | Respirent Pharmaceuticals Co Ltd. | 2020-09-01 |
| Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid (NCT04326959) | PT. Prodia Stem Cell Indonesia | 2020-09-01 |
| Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors (NCT04260009) | Takeda | 2020-09-01 |
| 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer (NCT04487847) | Radboud University Medical Center | 2020-09-01 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans (NCT04506645) | Regeneron Pharmaceuticals | 2020-09-01 |
| Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old (NCT04714229) | EuBiologics Co.,Ltd | 2020-09-01 |
| PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer (NCT04612530) | Amsterdam UMC, location VUmc | 2020-09-01 |
| STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic (NCT05419167) | Université du Québec à Trois-Rivières | 2020-09-01 |
| ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies (NCT04412616) | Changchun Intellicrown Pharmaceutical Co. LTD | 2020-09-01 |
| A Study of JR-171 in Patients With Mucopolysaccharidosis I (NCT04227600) | JCR Pharmaceuticals Co., Ltd. | 2020-09-01 |
| Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid (NCT04411914) | Temple University | 2020-09-01 |
| Auditory Training and Hearing Aid Satisfaction (NCT04230876) | Washington University School of Medicine | 2020-09-01 |
| A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders (NCT04146285) | Bio-Thera Solutions | 2020-09-01 |
| Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults (NCT04494373) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2020-09-01 |
| Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers (NCT04404790) | Lee's Pharmaceutical Limited | 2020-09-01 |
| HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM (NCT04547621) | Huashan Hospital | 2020-09-01 |
| Systemic Erythropoietin Injection in Patients Having Optic Atrophy (NCT04680143) | Alexandria University | 2020-09-01 |
| Treatment of SARS Caused by COVID-19 With Ruxolitinib (NCT04334044) | Grupo Cooperativo de Hemopatías Malignas | 2020-09-01 |
| Pembrolizumab + Defactinib In Pleural Mesothelioma (NCT04201145) | Raphael Bueno, MD | 2020-09-01 |
| Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes (NCT04504045) | University of Southern Denmark | 2020-09-01 |
| Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke (NCT04123067) | Milton S. Hershey Medical Center | 2020-09-01 |
| Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants (NCT05274100) | AbbVie | 2020-09-01 |
| Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer (NCT04294628) | National Cancer Institute (NCI) | 2020-09-01 |
| Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors (NCT04299191) | Laminar Pharmaceuticals | 2020-09-01 |
| Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas (NCT04407741) | Chinese PLA General Hospital | 2020-09-01 |
| A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma (NCT04316091) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-01 |
| Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia (NCT04540926) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2020-09-01 |
| Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors (NCT04625062) | New York University | 2020-09-01 |
| Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients (NCT04300673) | Radboud University Medical Center | 2020-09-01 |
| Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment (NCT04567069) | The Second Hospital of Shandong University | 2020-09-01 |
| PAC-1 for Treatment of Refractory, Metastatic Kidney Cancer (NCT03927248) | HealthPartners Institute | 2020-09-01 |
| Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors (NCT04121442) | Buzzard Pharmaceuticals | 2020-09-01 |
| A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors (NCT04073680) | Petra Pharma | 2020-09-01 |
| Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery (NCT04459065) | University of Saskatchewan | 2020-09-01 |
| An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease (NCT04519749) | 4D Molecular Therapeutics | 2020-09-01 |
| Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) (NCT04388761) | Tambi Jarmi | 2020-09-01 |
| Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19 (NCT04454398) | Sorrento Therapeutics, Inc. | 2020-09-01 |
| To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. (NCT04542447) | Natureceuticals Sdn Bhd | 2020-09-01 |
| Healthy Body, Healthy Bones After Bariatric Surgery Trial (NCT04279392) | University of Nebraska | 2020-09-01 |
| Primaquine Enantiomers in G6PD Deficient Human Volunteers (NCT04073953) | University of Mississippi, Oxford | 2020-09-01 |
| Ruxolitinib and Decitabine for High Risk Hematological Malignancies (NCT04582604) | Chinese PLA General Hospital | 2020-09-01 |
| Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER) (NCT04518878) | Peking University People's Hospital | 2020-08-31 |
| Study of COVID-19 DNA Vaccine (AG0302-COVID19) (NCT04527081) | AnGes, Inc. | 2020-08-31 |
| Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer (NCT04044430) | University of California, San Francisco | 2020-08-31 |